Figure 1. The mTOR paradox.

mTOR activation contributes to the transformation and growth of cancer cells but the prolonged stimulation of mTOR can also lead to stem cell depletion through the activation of senescence programs. The use of mTOR inhibitors or therapeutic agents resulting in inactivation of mTOR might protect adult stem cells from initiating premature cell senescence programs while concomitantly preventing tumor cell growth.